We support:

• Phase II–IV clinical trials
• IVD and diagnostic performance studies
• Device usability and human factors research
• Prospective biospecimen collection studies
• Observational and registry-based research
• Retrospective biospecimen retrieval
• Longitudinal and multi-timepoint sampling

Our integrated CRO + clinical site model allows for rapid, consistent, and high-quality study execution.

We have experience across more than six major therapeutic areas, including oncology, infectious diseases, respiratory conditions, endocrine and metabolic disorders, cardiovascular disease, women’s health, urology, and rare diseases.

We are able to expand into new therapeutic areas as required by the study.

Yes.

BioPartners provides complete end-to-end study management, including:

• Protocol development
• Feasibility & patient population assessments
• IRB submissions
• Monitoring & quality oversight
• Data and documentation management
• Study reporting and closeout

Sponsors may choose full-service support or individual services as needed.

Yes — this is one of our core strengths.

We operate as a global full-service CRO and an independent, actively enrolling clinical research site.

This dual structure reduces hand-offs, accelerates start-up, and ensures consistent oversight and documentation.